Literature DB >> 17580118

Aetiology and management of chylothorax in adults.

Sukumaran K Nair1, Matus Petko, Martin P Hayward.   

Abstract

Though rare in incidence, chylothorax can lead to significant morbidity and mortality. Its occurrence corresponds to increased mortality following esophagectomy. Leakage of chyle and lymph leads to significant loss of essential proteins, immunoglobulins, fat, vitamins, electrolytes and water. The presence of chylomicrons and a triglyceride level >110 mg/dl in the aspirated pleural fluid confirms the diagnosis of chylothorax. Identifying the aetiology using different diagnostic tests is important in planning treatment. While therapeutic thoracentesis provides relief from respiratory symptoms, the nutritional deficiency will continue to persist or deteriorate unless definitive therapeutic measures are instituted to stop leakage of chyle into the pleural space. Definitive therapy consists of obliteration and prevention of recurrence of chylothorax. Aggressive surgical therapy is recommended for post-traumatic or post-surgical chylothorax.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17580118     DOI: 10.1016/j.ejcts.2007.04.024

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  83 in total

1.  Reliability of Poirier's triangle in localizing the thoracic duct in the thorax.

Authors:  R Shane Tubbs; Nima Noordeh; Abhisek Parmar; Ayhan Cömert; Marios Loukas; Mohammadali M Shoja; Aaron A Cohen-Gadol
Journal:  Surg Radiol Anat       Date:  2010-05-18       Impact factor: 1.246

2.  Bilateral pleural effusions.

Authors:  Emmet E McGrath; Chris Barber
Journal:  CMAJ       Date:  2010-07-12       Impact factor: 8.262

Review 3.  The thoracic duct: clinical importance, anatomic variation, imaging, and embolization.

Authors:  Oren W Johnson; Jeffrey Forris Beecham Chick; Nikunj Rashmikant Chauhan; Alexandra Holmsen Fairchild; Chieh-Min Fan; Michael S Stecker; Timothy P Killoran; Alisa Suzuki-Han
Journal:  Eur Radiol       Date:  2015-12-01       Impact factor: 5.315

4.  Magnetic resonance lymphangiography with a nano-sized gadolinium-labeled dendrimer in small and large animal models.

Authors:  Laureen M Sena; Steven J Fishman; Kathy J Jenkins; Heng Xu; Martin W Brechbiel; Celeste A S Regino; Nobuyuki Kosaka; Marcelino Bernardo; Peter L Choyke; Hisataka Kobayashi
Journal:  Nanomedicine (Lond)       Date:  2010-10       Impact factor: 5.307

5.  Rapid development of chylothorax in patient with propofol-induced coma.

Authors:  Krzysztof Laudanski; A Joseph Layon
Journal:  BMJ Case Rep       Date:  2009-07-14

6.  Chylothorax: unusual complication after laparoscopic gastric banding.

Authors:  Carlos Zerrweck; Robert Caiazzo; Laurent Arnalsteen; Guélareh Dezfoulian; Henry Porte; François Pattou
Journal:  Obes Surg       Date:  2009-01-27       Impact factor: 4.129

Review 7.  Treatment options in patients with chylothorax.

Authors:  Hans H Schild; Christian P Strassburg; Armin Welz; Jörg Kalff
Journal:  Dtsch Arztebl Int       Date:  2013-11-29       Impact factor: 5.594

8.  Magnetic resonance-thoracic ductography: imaging aid for thoracic surgery and thoracic duct depiction based on embryological considerations.

Authors:  Itsuko Okuda; Harushi Udagawa; Junji Takahashi; Hiromi Yamase; Tadasu Kohno; Yasuo Nakajima
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-12

9.  Prophylactic thoracic duct mass ligation prevents chylothorax after transthoracic esophagectomy for cancer.

Authors:  Matteo Cagol; Alberto Ruol; Carlo Castoro; Rita Alfieri; Silvia Michieletto; Ermanno Ancona
Journal:  World J Surg       Date:  2009-08       Impact factor: 3.352

Review 10.  [Therapy management of chylothorax].

Authors:  S Bölükbas; N Kudelin; T Dönges; J Schirren
Journal:  Chirurg       Date:  2010-03       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.